Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer

IMPORTANCE: The spectrum of individual immune-related adverse events (irAEs) from anti–programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) immune checkpoint inhibitors (ICIs) has been reported widely, and their development is associated with improved patient survival across tum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Shankar, Bairavi, Zhang, Jiajia, Naqash, Abdul Rafeh, Forde, Patrick M., Feliciano, Josephine L., Marrone, Kristen A., Ettinger, David S., Hann, Christine L., Brahmer, Julie R., Ricciuti, Biagio, Owen, Dwight, Toi, Yukihiro, Walker, Paul, Otterson, Gregory A., Patel, Sandip H., Sugawara, Shunichi, Naidoo, Jarushka
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596677/
https://ncbi.nlm.nih.gov/pubmed/33119034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.5012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados